COLL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: COLL Shares Outstanding History and COLL YTD Return |
COLL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: COLL Shares Outstanding History and COLL YTD Return |
COLL Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+11.97% CAGR Mouse over chart for data details
|
COLL Stock Price Chart |
About Collegium Pharmaceutical Inc |
Collegium Pharmaceutical is a pharmaceutical company. Co.'s portfolio includes: Xtampza ER, Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol. Xtampza ER was approved by the U.S. Food and Drug Administration for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic. We show 37 historical shares outstanding datapoints in our COLL shares outstanding history coverage, used to compute COLL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing COLL market cap history over the course of time is important for investors interested in comparing COLL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of COLL versus a peer is one thing; comparing COLL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like COLL can fluctuate over the course of history. With this page we aim to empower investors researching COLL by allowing them to research the COLL market cap history. |
COLL Current Stock Quote |
Free COLL Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
COLL Share Performance |
Market Cap Peers |
Collegium Pharmaceuticals (COLL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
COM Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.